| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
230,290,000 |
| Market
Cap: |
138.17(K) |
| Last
Volume: |
11,847,187 |
Avg
Vol: |
11,814,994 |
| 52
Week Range: |
$0.0001 - $0.055 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Drug Manufacturers - Other |
|
Member Indexes:
|
| |
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
| |
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Endo International is a holding company. Through its subsidiaries, Co. is engaged in specialty pharmaceuticals. Co.'s segments are: Branded Pharmaceuticals, which includes branded products to treat and manage conditions in the areas of urology, orthopedics, endocrinology and bariatrics, among others; Sterile Injectables, which consists of branded sterile injectable products; Generic Pharmaceuticals, which includes generic product families that treat and manage a range of medical conditions; and International Pharmaceuticals, which includes products serving therapeutic areas, including attention deficit hyperactivity disorder, pain, women's health, oncology and transplantation.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-03-10 |
2023-12-08 |
2023-06-09 |
2022-06-09 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Hyatt Michael |
officerTitle |
– • – |
2006-01-24 |
4 |
S |
$27.52 |
$4,816,000 |
D/D |
(175,000) |
225,000 |
|
- |
|
| Black Jeffrey R |
officerTitle |
• – – |
2006-01-24 |
4 |
S |
$27.52 |
$18,420,512 |
D/D |
(669,350) |
358,518 |
|
- |
|
| Lankau Peter A |
officerTitle |
• • – |
2006-01-24 |
4 |
S |
$27.52 |
$909,481 |
D/D |
(33,048) |
23,747 |
|
- |
|
| Connors James J Ii |
officerTitle |
– – • |
2006-01-24 |
4 |
S |
$27.52 |
$217,872,070 |
I/I |
(7,916,863) |
8,986,544 |
|
- |
|
| Connors James J Ii |
officerTitle |
– – • |
2006-01-24 |
4 |
S |
$27.52 |
$198,797,545 |
I/I |
(7,223,748) |
8,199,778 |
|
- |
|
| Connors James J Ii |
officerTitle |
– – • |
2006-01-24 |
4 |
S |
$27.52 |
$215,525,082 |
I/I |
(7,831,580) |
8,889,737 |
|
- |
|
| Endo Pharma Llc |
officerTitle |
– – • |
2006-01-24 |
4 |
S |
$27.52 |
$257,759,365 |
D/D |
(9,366,256) |
10,631,770 |
|
- |
|
| Kimmel Roger H |
officerTitle |
– • – |
2006-01-04 |
4 |
AS |
$32.00 |
$836,096 |
I/I |
(26,128) |
448,047 |
|
- |
|
| Connors James J Ii |
officerTitle |
– – • |
2005-12-29 |
4 |
OE |
$3.00 |
$6,756 |
I/I |
2,252 |
15,605,616 |
|
- |
|
| Connors James J Ii |
officerTitle |
– – • |
2005-12-29 |
4 |
OE |
$3.00 |
$6,678 |
I/I |
2,226 |
15,423,526 |
|
- |
|
| Connors James J Ii |
officerTitle |
– – • |
2005-12-29 |
4 |
OE |
$3.00 |
$7,317 |
I/I |
2,439 |
16,903,407 |
|
- |
|
| Connors James J Ii |
officerTitle |
– – • |
2005-12-29 |
4 |
OE |
$3.00 |
$7,239 |
I/I |
2,413 |
16,721,317 |
|
- |
|
| Endo Pharma Llc |
officerTitle |
– – • |
2005-12-29 |
4 |
OE |
$3.00 |
$8,658 |
D/D |
2,886 |
19,998,026 |
|
- |
|
| Connors James J Ii |
officerTitle |
– – • |
2005-12-23 |
4 |
OE |
$3.00 |
$6,672 |
I/I |
2,224 |
15,425,752 |
|
- |
|
| Connors James J Ii |
officerTitle |
– – • |
2005-12-23 |
4 |
OE |
$3.00 |
$6,753 |
I/I |
2,251 |
15,607,868 |
|
- |
|
| Connors James J Ii |
officerTitle |
– – • |
2005-12-23 |
4 |
OE |
$3.00 |
$7,314 |
I/I |
2,438 |
16,905,846 |
|
- |
|
| Connors James J Ii |
officerTitle |
– – • |
2005-12-23 |
4 |
OE |
$3.00 |
$7,233 |
I/I |
2,411 |
16,723,730 |
|
- |
|
| Endo Pharma Llc |
officerTitle |
– – • |
2005-12-23 |
4 |
OE |
$3.00 |
$8,652 |
D/D |
2,884 |
20,000,912 |
|
- |
|
| Endo Pharma Llc |
10% Owner |
– – • |
2005-12-21 |
4 |
OE |
$3.00 |
$918,588 |
D/D |
306,196 |
20,003,796 |
|
- |
|
| Connors James J Ii |
officerTitle |
– – • |
2005-12-21 |
4 |
OE |
$3.00 |
$716,826 |
I/I |
238,942 |
15,610,119 |
|
- |
|
| Connors James J Ii |
officerTitle |
– – • |
2005-12-21 |
4 |
OE |
$3.00 |
$776,439 |
I/I |
258,813 |
16,908,284 |
|
- |
|
| Connors James J Ii |
officerTitle |
– – • |
2005-12-21 |
4 |
OE |
$3.00 |
$708,462 |
I/I |
236,154 |
15,427,976 |
|
- |
|
| Connors James J Ii |
officerTitle |
– – • |
2005-12-21 |
4 |
OE |
$3.00 |
$768,075 |
I/I |
256,025 |
16,726,142 |
|
- |
|
| Ammon Carol A |
officerTitle |
– • – |
2005-12-16 |
4 |
GD |
$0.00 |
$0 |
D/D |
124,391 |
2,736,842 |
|
- |
|
| Endo Pharma Llc |
10% Owner |
– – • |
2005-12-15 |
4 |
OE |
$2.42 |
$4,027 |
D/D |
1,664 |
20,309,992 |
|
- |
|
825 Records found
|
|
Page 18 of 33 |
|
|
